A biologic therapy that acts as a colony-stimulating factor, a substance made in the body that helps the bone marrow make white blood cells. Colony-stimulating factors may be given after chemotherapy to help prevent infections. They may also be used after bone marrow and stem cell transplantation to help bone marrow recover.

A colony-stimulating factor that stimulates the production of blood cells, especially platelets, during chemotherapy. It is a cytokine that belongs to the family of drugs called hematopoietic (blood forming) agents. Also called granulocyte colony-stimula

The generic name for a growth factor produced by recombinant DNA technology that occurs naturally in humans and stimulates production of white blood cells called granulocytes. Filgrastim is also known by the trade name, Neupogen, or as G-CSF ( granulocyte-colony stimulating factor).

A protein that helps bone marrow make more white blood cells. Filgrastim is also known as GCSF (granulocyte-colony stimulating factor) or by the tradename Neupogen®. It is given to donors who have agreed to donate peripheral blood stem cells. This moves blood stem cells from the marrow into the blood stream so that they can be collected by apheresis. It is also given to patients to help increase their white blood cell count after the transplant.

A colony-stimulating factor that stimulates the production of neutrophils (a type of white blood cell). It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. Also called granulocyte colony-stimulating factor (G-CSF).

Filgrastim is a granulocyte colony-stimulating factor (G-CSF) analog used to stimulate the proliferation and differentiation of granulocytes. It is produced by recombinant DNA technology. The gene for human granulocyte colony-stimulating factor is inserted into the genetic material of Escherichia coli.